Bills Seek to Strengthen U.S. Information Policy

WASHINGTON—The government’s management of scientific and technical information came under heavy fire last month at a congressional hearing. Witnesses charged that the Reagan administration has failed to develop a coherent national policy, and attacked its plans to broaden security restrictions on such information and sell off the National Technical Information Services (NTIS), the nation’s largest repository of technical material. The hearing before the Science, Research a

Written byKris Herbst
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON—The government’s management of scientific and technical information came under heavy fire last month at a congressional hearing. Witnesses charged that the Reagan administration has failed to develop a coherent national policy, and attacked its plans to broaden security restrictions on such information and sell off the National Technical Information Services (NTIS), the nation’s largest repository of technical material.

The hearing before the Science, Research and Technology subcommittee of the House Science, Space and Technology Committee also showcased bills by subcommittee chairman Rep. Doug Waigren (D-Pa.) and ranking member Rep. George Brown (D-Calif.). Brown’s bill (H.R. 1615) would create a centralized Government Information Agency to collect, maintain and distribute all R&D information generated by or for the federal government, while Walgren’s bill (H.R. 2159) would make NTIS a government corporation.

Neither Walgren’s bill, which would protect NTIS by removing it from the Commerce Department, nor Brown’s bill, which would make ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies